The
confidential portions of this exhibit have been filed separately
with the Securities and Exchange Commission pursuant to a
confidential treatment request in accordance with Rule 24b-2 of the
Securities and Exchange Act of 1934, as amended. REDACTED
PORTIONS OF THIS EXHIBIT ARE MARKED BY AN [##].
FIRST AMENDMENT TO
SERVICES AGREEMENT
This First Amendment (the
“Amendment”) made as of October 20, 2008 (the
“Effective Date”) by and between Ventiv Commercial
Services, LLC a New Jersey limited liability company
(“Ventiv”) and OMP, Inc., a Delaware corporation
(“Obagi”). Ventiv and Obagi may each be
referred to herein as a “Party” and collectively, the
“Parties”.
W I T N E S S E T H:
WHEREAS, Ventiv and Obagi are parties to a
Service Agreement made as of July 1, 2008 (the
“Agreement”).
WHEREAS, Ventiv and Obagi desire to supplement
the Agreement as set forth herein.
NOW THEREFORE, in consideration of the premises
and other good and valuable consideration, the receipt and adequacy
of which is hereby acknowledged, it is agreed as
follows:
1. Except as provided
in this Amendment, the terms and conditions set forth in the
Agreement remain unaffected by the execution of this
Amendment. To the extent that any provisions or terms
set forth in this Amendment conflict with the terms set forth in
the Agreement, the terms set forth in this Amendment shall govern
and control. Terms not otherwise defined herein, shall
have the meanings set forth in the Agreement.
2. Ventiv and Obagi
desire to expand the services being provided by Ventiv as set forth
in the Agreement. Ventiv, through its Ventiv Access
Group division, shall provide Obagi with the services set forth in
detail in Exhibit A (the “VAG
Services”). For provision of the VAG Services,
Obagi shall pay Ventiv the compensation set forth in Exhibit
A.
3. Ventiv shall
provide the VAG Services commencing on the Effective Date and
continuing until April 1, 2009 (the
“Term”). Obagi may terminate Ventiv’s
provision of the VAG Services prior to the end of the Term by
providing Ventiv with at least thirty (30) days prior
written
notice. Obagi may extend the Term for up to two (2)
successive ninety (90) day periods (each an “Additional
Term”) by providing Ventiv with written notice at least
thirty (30) days prior to the end of the initial Term or any
Additional Term. The compensation to be paid by Obagi to
Ventiv for any period beyond the two (2) Additional Terms must be
agreed to in writing by the Parties.
4. The terms of this
Amendment are intended by the Parties to be the final expression of
their agreement with respect to the subject matter hereof and may
not be contradicted by evidence of any prior or contemporaneous
agreement. The Parties further intend that this
Amendment constitute the complete and exclusive statement of its
terms and shall supersede any prior agreement with respect to the
subject matter hereof.
5. This Amendment may
be executed simultaneously in multiple counterparts, each of which
shall be deemed an original, but all of which taken together shall
constitute one and the same instrument. Execution and
delivery of this Amendment by exchange of facsimile copies bearing
the facsimile signature of a party hereto shall constitute a valid
and binding execution and delivery of this Amendment by such
party. Such facsimile copies shall constitute
enforceable original documents.
WHEREFORE, the
Parties hereto have caused this Amendment to be executed by their
duly authorized representatives.
|
VENTIV COMMERCIAL SERVICES, LLC
|
|
|
|
|
|
By: /s/
TERRELL G. HERRING
|
|
|
|
|
|
Terrell G.
Herring
|
|
|
|
|
President and
Chief Executive Officer
|
|
|
|
|
|
|
|
|
|
|
|
OMP,
INC.
|
|
|
|
|
|
By: /s/
PRESTON ROMM
|
|
|
|
|
|
Preston
Romm
|
|
|
|
|
|
|
|
|
|
|
SERVICES AND
COMPENSATION
Ventiv shall provide Obagi with one part-time
(50% time allocation) National Account Manager
(“NAM”). The NAM shall have the
qualifications set forth on Exhibit B attached to this
Amendment.
Ventiv shall also provide Obagi with the
following services.
A)
PRIMARY RESEARCH
|
|
VAS shall
complete a maximum of 10 telephone interviews with targeted MCO and
PBM stakeholders who are geographically dispersed within the United
States. A minimum of 5 interviews will be
conducted.
|
|
|
VAS shall
complete a maximum of 7 telephone interviews with targeted retail
pharmacies that are geographically dispersed
|